SCHEMBL4737360

SCHEMBL4737360

CNC(=O)c1ccc(-c2cc3c(c(C(=O)O)c2)OCCO3)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.52
KDM4E B2RXH2 3/20 0.42
HPGD P15428 3/20 0.42
TP53 P04637 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
ALDH1A1 P00352 2/20 0.42
HSD17B10 Q99714 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
BAZ2B Q9UIF8 1/20 0.41
ADCY1 Q08828 3/20 0.41
LTB4R Q15722 1/20 0.40
LTB4R2 Q9NPC1 1/20 0.40
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
ALOX15 P16050 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4786603 0.86 PLK1 (0.49) PLK1NPC1BAZ2BLTB4RLTB4R2
SCHEMBL4735845 0.85 KDM4E (0.46) PLK1KDM4EHPGDTP53NPC1
SCHEMBL4640382 0.85 PLK1 (0.50) PLK1KDM4EHPGDTP53NPC1
SCHEMBL4740181 0.84 CRBN (0.41) PLK1NPC1RAB9AALDH1A1CRBN
SCHEMBL4640340 0.83 PLK1 (0.43) PLK1KDM4EHPGDTP53NPC1
SCHEMBL4735326 0.83 TSHR (0.49) KDM4EHPGDTP53NPC1RAB9A
SCHEMBL4737031 0.82 SMN1; SMN2 (0.50) KDM4EHPGDTP53NPC1RAB9A
SCHEMBL4737367 0.82 ACMSD (0.47) KDM4EHPGDTP53NPC1RAB9A
SCHEMBL4735085 0.82 AKR1C2 (0.52) KDM4EHPGDTP53NPC1RAB9A
SCHEMBL4785991 0.81 KDM4E (0.45) KDM4EHPGDTP53NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207728-A1 BICYCLIC ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-08-28 US claimed
WO-2008071455-A1 BICYCLIC ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-06-19 WO claimed
US-20080207728-A1 BICYCLIC ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-08-28 US disclosed
WO-2008071455-A1 BICYCLIC ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207728-A1 BICYCLIC ACYLTRYPTOPHANOLS FSHR, GNRHR, TPH1 PLK1 1294/4885KDM4E 2247/4885HPGD 2641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.